Virbac

Equities

VIRP

FR0000031577

Pharmaceuticals

Market Closed - Euronext Paris 12:35:11 2024-03-28 pm EDT 5-day change 1st Jan Change
346 EUR +2.22% Intraday chart for Virbac +0.87% -3.76%

This article is for Premium subscribers only

Signed up already?

Log In

Not subscribed yet?

Subscribe
VIRBAC : Oddo BHF maintains its recommendation on the stock CF
CAC40: damage limited despite Kering's fall CF
Transcript : Virbac SA, 2023 Earnings Call, Mar 20, 2024
Virbac: net income unchanged overall in 2023 CF
Virbac Sa Provides Earnings Guidance for the Year 2024 CI
Virbac Sa Proposes Dividend for the Year 2023 CI
Virbac SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
CAC40: modest rise, driven by Legrand and Renault CF
CAC40: tests 7.960, E-Stoxx50 at its zenith, oil tests $84 CF
CAC40: back to 7,960, gold sets a new record at $2,144 CF
CAC40: erases previous day's losses, tops 7950 pts CF
Virbac to Buy Orix's Animal Health Unit MT
Virbac: acquisition of Sasaeah in Japan CF
Virbac SA entered into a definitive agreement to acquire Sasaea Holdings Co., Ltd. from ORIX Corporation for an enterprise value of approximately ?280 million. CI
Virbac: the Board co-opts Mr. Charmeil as Director CF
VIRBAC : Modest beat in Q4; 2024 outlook maintained Alphavalue
Stifel Keeps Virbac at Hold, Boosts PT MT
VIRBAC : Stifel raises its target price CF
Virbac: sales up 4.6% in 2023 CF
Virbac SA Provides Earnings Guidance for the Year 2024 CI
Virbac Sa Reports Revenue Results for the Fourth Quarter and Full Year Ended December 2023 CI
Biote Appoints Robert Peterson as CFO MT
Virbac: one of the SBF120's top performers in 2023 CF
VIRBAC : Onboarding some steady improvements Alphavalue
Virbac: up sharply, a broker raises his target sharply CF
Chart Virbac
More charts
Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.8%), Europe (24.9%), Asia (17.5%), Latin America (16.2%), North America (13.3%), Pacific (9.7%), Africa and Middle East (2.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
346 EUR
Average target price
351.3 EUR
Spread / Average Target
+1.52%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Virbac - Euronext Paris
  4. News Virbac
  5. Virbac : A French leader in animal health